Abeona Therapeutics Inc. (NASDAQ: ABEO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ABEONA THERAPEUTICS INC.

Abeona Therapeutics Inc. (NASDAQ: ABEO)
Listen to this Section


$5.54
N/A ( +1.28% ) 237.5K

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Market Data


Open $5.54
Previous Close $5.54
Volume 237.5K
Market Cap $240.83M
Day Range $5.47 - $5.67
52 Week Range $3.05 - $9.01
Shares Outstanding 43.47M
Change % +1.28%
Net Change N/A
Insider Ownership -0.01%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 1980
Country United States

Insider Ownership Transactions

Total Amount Purchased: 4,898,839.00

Date Type Amount Purchased Purchaser
2024-08-14 Sale -11044.00 Crombez Eric
2024-08-14 Sale -11044.00 Zeiher Bernhardt G
2024-07-22 Sale -1055.00 Vazzano Joseph Walter
2024-07-09 Sale -155200.00 Vazzano Joseph Walter
2024-07-09 Sale -23611.00 Alvino Mark
2024-07-09 Sale -23611.00 Charles Faith L.
2024-07-09 Sale -23611.00 Amoroso Michael
2024-07-09 Sale -102689.00 O'Malley Brendan M.
2024-07-09 Sale -424000.00 Seshadri Vishwas
2024-07-09 Sale -23611.00 Alland Leila

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Apr 26, 2024
4 Insider transactions 1 Apr 26, 2024
4 Insider transactions 1 Apr 26, 2024
8-k 8K-related 13 Apr 24, 2024
8-k 8K-related 13 Apr 24, 2024
8-k 8K-related 15 Apr 22, 2024
8-k 8K-related 15 Apr 22, 2024
def Proxies and info statements 5 Mar 19, 2024
def Proxies and info statements 5 Mar 19, 2024
10-k Annual reports 87 Mar 18, 2024

Latest News


× Before browsing our site, please accept our cookies policy